NCT06715020View on ClinicalTrials.gov

Establishment and Clinical Transformation of ADC Drug Efficacy Evaluation System for Breast Cancer Based on Molecular Imaging

NANot yet recruitingINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

December 31, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Breast Cancer

Interventions

DRUG

18F-FDG

All study participants will undergo one 18F-FDG PET scan.

All Listed Sponsors

collaborator

Yunnan Cancer Hospital

OTHER

lead

Peking University Cancer Hospital & Institute

OTHER